Europe — EMA

Onivyde Pegylated Liposomal (Irinotecan)

Irinotecan, the active ingredient in Onivyde, is a topoisomerase I inhibitor presented as a sterile lyophilized powder for intravenous infusion use.

Irinotecan

Request sourcing

Pack/s

What is Irinotecan?

Irinotecan, the active ingredient in Onivyde, is a topoisomerase I inhibitor presented as a sterile lyophilized powder for intravenous infusion use. It is employed in the treatment of metastatic metastatic metastatic metastatic metastatic ...

GNH USA supplies Onivyde as a licensed ... worldwide.

What is Irinotecan used for?

Onivyde ... t ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →